Skip to main content
| News

Basel Area supporting three digital health startups

17.01.2022

Basel Area Business & Innovation will be offering intensive support to the three winners of its DayOne Digital Health Accelerator 2022. The successful startups come from Portugal, the UK and Israel. The focus of their activities is on developing innovative solutions for pain management.

The investment and innovation promotion agency Basel Area Business & Innovation has selected the winners of the fourth edition of its DayOne Digital Health Accelerator. According to a press release, a total of 16 of the 128 applications submitted from 43 countries met the criteria for this year’s focus on pain management particularly well. Three of these have now been selected to take part in this three-month acceleration program, which is set to begin in mid-January.

Hope Care from Obidos in Portugal has developed the digital solution HCAlert to remotely monitor sick people. This reduces the cost of hospital stays and emergencies. HCAlert is already available in Portugal, while the product will now also be launched in the German-speaking DACH region of Germany, Austria and Switzerland, the Benelux countries and Italy.

Based in the Welsh capital city of Cardiff, the British startup Rescape Innovation has developed three medical devices to ease pain in addition to helping with anxiety and stress management. These are intended for use by adults, children and care staff.  The devices work on the basis of virtual reality distraction therapy and are all already available on the UK market.

With its digital health technology, the Israeli startup TrainPain targets chronic pain, with a specific focus on neuropathic and nociplastic pain. It aims to liberate chronic pain sufferers from a life of persistent pain. Market launches are planned in the USA, Europe and Asia.

Excited about the future

The DayOne Accelerator is, according to information in the press release, the largest accelerator platform for startups operating in the field of digital health and medical engineering in Switzerland and Europe. It is divided into three areas: Digital Health, Tech and Digital Health Nation. “This model represents the future of early-stage venture capital in healthcare and a new, accelerated way to bring innovation to the healthcare industry”, comments DayOne Director Lucas Scherdel in the press release. “We’re excited about the future of the industry and of Switzerland and the Basel Area as a flourishing hub for digital health innovation”, he adds.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

BeiGene opens European headquarters in Basel
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

BeiGene opens European headquarters in Basel

BeiGene has opened its new European headquarters in Basel. The global biotech specializing in innovative cancer treatments intends to build...

Read More
The 25 Best AI Courses in the Basel Area, Germany and France
Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation

The 25 Best AI Courses in the Basel Area, Germany and France

Artificial Intelligence (AI) offers numerous possible applications. But how, where and regarding which focal points can you get further training...

Read More
Engimmune Therapeutics banks 15.5 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Engimmune Therapeutics banks 15.5 million Swiss francs

Engimmune Therapeutics will now be in a position to drive forward its innovative platforms for the development of T-cell therapies...

Read More
Bionter receives 3 million US dollars in investments
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Bionter receives 3 million US dollars in investments

Bionter AG has received 3 million US dollars in a seed funding round. These funds will enable Bionter to bring...

Read More
Resistell seeking to further develop test to combat antibiotic resistance
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Resistell seeking to further develop test to combat antibiotic resistance

The startup Resistell has launched a study looking into the applicability of a test against antibiotic resistances that is being...

Read More
Biotech startup Cimeio receives 46 million Swiss francs for cell therapy
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Biotech startup Cimeio receives 46 million Swiss francs for cell therapy

Cimeio Therapeutics from Basel has received initial financing amounting to 46 million Swiss francs from Versant Ventures. The startup is...

Read More
1 2 3 24

Do you have a question? We'd like to hear from you.